InvestorsHub Logo
Followers 0
Posts 47
Boards Moderated 0
Alias Born 06/16/2015

Re: None

Monday, 01/30/2023 12:08:02 PM

Monday, January 30, 2023 12:08:02 PM

Post# of 660

Truist $AXSM BUY $150PT We polled 43 psychiatrists who have prescribed Auvelity since launch and overall feedback is highly positive. Based on positive initial real-world psychiatrist feedbacks, we think Auvelity may outpace our sales forecast of ~$1BN by 2034.

Truist $AXSM Encouragingly, 98% of psychiatrists have stated that, based on their experience with Auvelity, they would prescribe Auvelity to other MDD patients under their care.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXSM News